BenQ Medical Technology (4116) — Cash Flow Reinvestment Rate
BenQ Medical Technology (4116) has a Cash Flow Reinvestment Rate of 0.42x as of June 2025, reinvesting NT$76.10 Million (capex NT$14.79 Million plus investments NT$-61.31 Million) from operating cash flow of NT$179.07 Million. Explore BenQ Medical Technology capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BenQ Medical Technology Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for BenQ Medical Technology across 8 annual periods. Also explore BenQ Medical Technology asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for BenQ Medical Technology (2017–2024)
Year-by-year capital reinvestment analysis for BenQ Medical Technology. For live market cap and broader valuation context, see BenQ Medical Technology market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.88x | NT$195.80 Million | NT$222.22 Million | NT$175.48 Million | ▲ +45.5% |
| 2023 | 0.61x | NT$267.96 Million | NT$442.35 Million | NT$139.28 Million | ▲ +39.9% |
| 2022 | 0.43x | NT$164.04 Million | NT$378.77 Million | NT$60.05 Million | ▼ -45.2% |
| 2021 | 0.79x | NT$95.91 Million | NT$121.35 Million | NT$32.92 Million | ▲ +54.4% |
| 2020 | 0.51x | NT$77.53 Million | NT$151.48 Million | NT$42.37 Million | ▲ +205.9% |
| 2019 | 0.17x | NT$28.32 Million | NT$169.23 Million | NT$21.15 Million | ▼ -57.1% |
| 2018 | 0.39x | NT$49.21 Million | NT$126.10 Million | NT$31.36 Million | ▼ -77.9% |
| 2017 | 1.77x | NT$128.91 Million | NT$72.97 Million | NT$112.31 Million | — |